Detalles de la búsqueda
1.
Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccination.
Br J Haematol
; 202(6): 1091-1103, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37402627
2.
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy.
Br J Haematol
; 191(2): 194-206, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32678948
3.
Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.
Biol Blood Marrow Transplant
; 25(3): 443-450, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30935664
4.
CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status.
Blood
; 125(4): 731-9, 2015 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-25499763
5.
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 22(7): 1234-1241, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27095691
6.
Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies.
Br J Haematol
; 195(5): 706-709, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34545952
7.
Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin Lymphoma.
Br J Haematol
; 171(2): 197-204, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26119524
8.
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.
Br J Haematol
; 191(3): 505-506, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33103782
9.
A reply to Hurley et al. regarding Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.
Biol Blood Marrow Transplant
; 25(8): e270-e271, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31195138
10.
Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure.
Br J Haematol
; 165(3): 334-40, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24438080
11.
Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia.
Br J Haematol
; 187(1): e20-e24, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31396948
12.
Allogeneic transplantation in the UK: an aggregation of marginal gains?
Br J Haematol
; 163(2): 149-59, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23889234
13.
Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning.
Br J Haematol
; 161(4): 578-86, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23496350
14.
Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia.
Br J Haematol
; 160(5): 640-8, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23293871
15.
Adenoviremia has limited clinical impact in the majority of patients following alemtuzumab-based allogeneic stem cell transplantation in adults.
Clin Infect Dis
; 55(10): 1362-70, 2012 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22903766
16.
Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failure.
Br J Haematol
; 156(4): 516-22, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22171699
17.
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning.
Blood
; 115(25): 5147-53, 2010 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20371745
18.
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma.
Blood
; 115(14): 2763-8, 2010 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-20124510
19.
Antifungal stewardship: towards defining safe stopping criteria for therapeutic oral azoles.
Br J Haematol
; 172(2): 285-7, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25939287
20.
Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation.
Transplant Cell Ther
; 27(8): 682.e1-682.e12, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33962069